tirzepatide age limit Restrictions For Mounjaro: Who Can Use It? Eli Lilly launches weight-loss drug
Description
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the naturally occurring incretin hormone GLP-1

#GLP1 #ObesityCare #DigitalHealth #PopulationHealth #NovoNordisk #Wegovy #ValueBasedCare

Kind Intelligence Foundry's first product, Glo, is an SMS-based AI companion for people on GLP-1 medications such as Ozempic, Wegovy, Zepbound, and Mounjaro, ...

After adjustment for sex, BMI, hsCRP, and sCD163, semaglutide significantly decreased epigenetic aging: PCGrimAge (-3.1 years, P = 0.007), GrimAge V1 (-1.4 years, P = 0.02), GrimAge V2 (-2.3 years, P = 0.009), PhenoAge (-4.9 years, P = 0.004), and DunedinPACE (-0.09 units, 9 % slower pace, P = 0.01)
Recent Findings GLP-1 agonists may be associated with breast changes and symptoms that warrant further breast imaging, including supplemental screening and/or for problem solving in the appropriate clinical scenario

Ozempic will be a 'big disruptor for the food industry,' says Mattson, which is expanding to Chicago with the acquisition of Hyde Park Group.
